Catalyst Pharmaceuticals ...

NASDAQ: CPRX · Real-Time Price · USD
20.23
0.16 (0.80%)
At close: Aug 15, 2025, 3:59 PM
20.15
-0.37%
After-hours: Aug 15, 2025, 07:54 PM EDT

Catalyst Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
52.11M 56.74M 55.94M 43.88M 40.79M 23.27M 34.84M -30.76M 37.76M 29.57M 25.47M 22.75M 21.62M 13.24M 9.31M 10.33M 12.18M 7.66M
Depreciation & Amortization
9.46M 9.46M 9.46M 9.45M 9.5M 9.43M 9.14M 8.57M 8.57M 6.6M 615K 553K 37K 34K 33K 31K 31K 97K
Stock-Based Compensation
7.6M 5.85M 5.17M 4.42M 4.41M 8.25M 4.25M 3.81M 3.3M 2.89M 1.93M 2.06M 2.02M 1.9M 1.47M 1.51M 1.52M 1.57M
Other Working Capital
n/a 4.37M 6.15M 25.12M 6.53M 7.17M 9.53M -251K -6.92M 22.97M 10.05M 9.5M 2.87M -7.14M 6.43M 7.79M 2.15M -6.01M
Other Non-Cash Items
-2.48M -2.63M -6.69M -2.77M 23.7M 153K -1.13M 81.07M 65K 194K 63K 4.14M 706K 58K 80K 105K 108K -6K
Deferred Income Tax
-2.43M -2.32M 2.56M -8.58M -1.61M -1.75M 883K -13.94M -3.24M -1.52M 1.28M 934K 817K 1.9M 2.75M 2.3M 2.72M 1.55M
Change in Working Capital
7.05M -7.05M 4.45M 26.47M 8.65M -8.65M 7.65M -3.61M -15.7M -25.66M 10.72M 10.68M 989K -8.66M 5.54M 7.43M -883K -7.06M
Operating Cash Flow
71.3M 60.04M 70.88M 72.87M 64.14M 31.93M 55.65M 45.13M 30.75M 12.07M 40.08M 41.3M 26.19M 8.48M 19.18M 21.71M 15.68M 3.81M
Capital Expenditures
-26K n/a -88K -259K -10K -199K -36.09M -79.35M n/a -74K -992K -10M -29K n/a -41K -68K -1K -911K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -13.46M n/a n/a -10M n/a n/a n/a n/a n/a -4M -6M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -19.24M 9.87M 9.37M n/a 5M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -2.23M -79.29M n/a -162.29M 659K 9.87M 9.37M n/a -5M n/a -4M -6M
Investing Cash Flow
-26K n/a -88K -259K -10K -199K -38.32M -92.82M n/a -162.37M -29.57M -132K 9.34M n/a -41K -68K -4M -6.91M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 296K n/a -296K -453K n/a -52K -477K -210K n/a -4.38M -2.55M -3.21M -5.05M -3.98M 293K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
872K 3.06M n/a -5.97M 1.16M 345K -665K -10.13M -214K 149K 2.25M 3.98M 1.36M 1M 549K 2.96M 254K 188K
Financial Cash Flow
872K 3.06M 4.43M -5.97M 1.16M 141.05M -665K -10.13M -214K 149K 2.25M 3.98M -2.99M -1.55M -2.53M -2.1M -3.71M 188K
Net Cash Flow
72.14M 63.1M 75.22M 66.64M 65.28M 172.78M 16.66M -57.82M 30.54M -150.15M 42.33M 45.15M 32.54M 6.93M 16.61M 19.54M 7.97M -2.91M
Free Cash Flow
71.27M 60.04M 70.79M 72.61M 64.13M 31.73M 19.55M -34.22M 30.75M 12M 39.09M 31.3M 26.16M 8.48M 19.14M 21.64M 15.67M 2.9M